基本資料
種類: ETF
費用比率%: 0.54
資產淨值: 38.97
成立日期: 30/10/2024
 
分析
市值分佈:
65.99%
大市值
29.18%
中市值
3.41%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 02/05/2026 06:10) 總持有投資項目: 39  
0%
 
100%
     10大 (54.88%)
代號 名稱 佔比% 持有日期
CRVSCorvus Pharmaceuticals1.5928/04/2026
GMEDGlobus Medical1.4429/04/2026
VRDNViridian Therapeutics1.4229/04/2026
DNTHDianthus Therapeutics1.4229/04/2026
WAYWaystar Holding Corp1.4129/04/2026
ITGRInteger Holdings Corp1.4029/04/2026
XERSXeris Biopharma Holdings1.2629/04/2026
BLLNBilliontoone Inc1.2629/04/2026
HNGEHinge Health Inc.1.1028/04/2026
WVEWave Life Sciences Ltd1.0829/04/2026
TWSTTwist Bioscience Corp1.0229/04/2026
LMRILumexa Imaging Holdings, Inc.0.9029/04/2026
RDNTRadNet0.8429/04/2026
INSMInsmed Incorporated0.8229/04/2026
KRROKorro Bio0.8029/04/2026
ATECAlphatec Holdings0.7329/04/2026
AVAHAveanna Healthcare Holdings0.7029/04/2026
NEONeoGenomics0.3928/04/2026
ALMRAlamar Biosciences Inc0.2329/04/2026
  1   2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.